Expert insights. Personalized for you.
We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. Back then, Dr. Sisley just entered the national spotlight, known as the research doctor who’d been unfairly fired from the University of Arizona for simply trying to study medical marijuana. The court gave the DEA 30 days to respond to Dr. Sisley, SRI, and the other researchers who filed suit. MORE
Raphael Mechoulam , an Israel bio-chemist and trailblazing cannabis researcher, announced last month a process to produce synthetic cannabinoid acids – chemical compounds that may be more stable than their plant-based counterparts. “This is exciting and unprecedented research,” said Dr. Mechoulam said in a press release. ” Dr. Mechaloum has been on the forefront of cannabis research for sixty years. Israel Leading the Way in Canna-Research and Policy. MORE
MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. MMJ will be utilizing its new products for an FDA approved treatment of multiple sclerosis (MS) and Huntington’s disease (HD). MORE
Yang Qu says: Cannabis is rapidly being transformed from an underground species into an industrial crop that awaits medical and agricultural development. The post UNB researcher receives grant to explore medical potential of cannabis appeared first on Cannabis News | Lifestyle Tips | Expert Opinions | Stocks. MORE
It is no surprise hence, given the relationship between cannabis users and heavy mobile app and internet use, that the cannabis industry is leveraging the next wave of technologies to fill knowledge gaps and accelerate awareness of research insights about consumers in adult-use cannabis and medical cannabis markets, in what is being referred to as Cannabis 3.0. Clinical trials are medical research projects involving human participants. Authored By : Arundati Dandapani. MORE
OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”). Valencia has stewarded Sapphire in the development of its unique patent-pending pipeline. “Sapphire Biotech’s research team is making impressive progress in the field of oncology, which is one of the main reasons we were attracted to the company,” said John W. MORE
In September of last year, Johns Hopkins University announced the launch of the nation’s first-ever psychedelic research center , a $17-million project to study the … Read More. Psy Business & Law News Partnered With CFN MORE
On Tuesday, July 21, the Food and Drug Administration (“FDA”) released draft guidance for clinical research related to the development and manufacturing of cannabis-based drugs, which gained particular interest following the legalization of hemp in December 2018. MORE
The commission tasked with developing recommendations to improve mental health treatment for veterans concluded: Congress and the executive branch need to promote research into the therapeutic potential of cannabis and psychedelics such as psilocybin mushrooms and MDMA. Throughout its research and deliberation processes, the commission put the needs of veterans at the heart of its work. Research is Limited Due to Many Obstacles. MORE
At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts. What you may not know is that the federal government actually has its own stash of cannabis for limited patient distribution and limited research purposes that it houses at the University of Mississippi (a/k/a) Ole Miss in Oxford, Mississippi. MORE
The post Is the Multidisciplinary Association for Psychedelic Studies (MAPS) too wedded to existing structures to truly make changes in development of psychedelics research first appeared on Cannabis Law Report. MORE
The polyps form inside the common and develop into colon cancers over time. Researchers looked at the activation of the cannabinoid receptor type 2 as a way of preventing colitis-associated colon cancer by myeloid cell deactivation of what is called the “upstream of IL-22 production”. MORE
The latest research suggests the endocannabinoid system and male reproductive system share a complex and extensive connection, bringing scientists closer to understanding how cannabis affects men’s fertility. The post Study finds endocannabinoid system regulates sperm development appeared first on Leafly. MORE
In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. In the developing world, the rates of amyotrophic lateral sclerosis are under-investigated, but in Europe and North America ALS afflicts 2 per 100,000 people each year. Exploring the available research on ALS and cannabinoids. MORE
SYDNEY, Australia – August 20, 2019 – The Office of Drug Control (ODC has announced the approval of Oz Medicann Pty Ltd licence for both Medicinal Cannabis and Cannabis Research. With these licences, Oz Medicann forges ahead with its evidence-based research across the whole cycle from seed to patient. This exciting development will allow the group to continue pioneering as an Australian medicinal cannabis healthcare company. MEDICAL CANNABIS RESEARCH MORE
ASX-listed MGC Pharmaceuticals has partnered with the Slovenian Institute of Hop Research and Brewing, or “IHPS”, to carry out a ground-breaking, large-scale research project on the use of cannabis for medical purposes. IHPS is a public research, developmental, advisory and educational organisation principally focussed on research and advice in growing plants. MORE
Whether or not cannabis use during pregnancy causes physical, cognitive, or mental impairments later in life has been something scientists and researchers have been investigating for decades. Unfortunately, much of the research conducted thus far have not shown the whole picture or clinical implications for children in real life. How Researchers Performed The Review. The research was conducted by Ciara A. News Research MORE
Research Team to Study the Impact of CBD on Spinal Injury Pain. Professor Luke Henderson is set to be the study’s lead investigator and he explains that the unfortunate truth for more than half of spinal cord injury patients is the development of chronic pain. MORE
The Partnership Seeks to Develop Cannabis-Based Products for the Treatment of Human Diseases, Beginning with Colon Cancer. CIB has a national reputation as a center of excellence for biological research,” said Brian Baca, CEO of Ikänik Farms. “We We look forward to working with some of Colombia’s leading academics, including clinical and technological specialists, to advance the development of cannabis-based medical treatments.”. MORE
NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabis worldwide, and UFC®, the world’s premier mixed martial arts organization, are excited to announce an exclusive, multi-year, multi-million dollar, global partnership that is expected to significantly advance further clinical research on the relationship between 100% hemp […]. EDMONTON, May 21, 2019 /CNW/ – Aurora Cannabis Inc. MORE
The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon. Researched and developed by Slovenia’s leading dermatologist, Dr Rok Devjak, MD PhD, over an 80 day period, Dr Devjak tested three of MGC Pharma’s upcoming products. MORE
Now that retailers broadly sell CBD oil, it offers a number of challenges and opportunities to medical researchers. Preliminary Research on CBD Oil. Pharmacies, as more profitable companies, have the resources to research the other cannabinoids present in CBD oil. Pharmacies partner with companies that have an interest in cannabis research. Hospitals and universities have always been at the forefront of research on cannabis products. MORE
SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. We’ll hand them an iPad, and ask them to fill out a couple quick surveys,” said Michael McDonell, chair of WSU’s Collaboration on Cannabis Policy, Research and Outreach. McDonell said research institutions are limited in their access to cannabis users by federal laws that could affect funding. MORE
Until recently, there has been little to no research available that examines the effects of cannabis in patients diagnosed with Obsessive-Compulsive Disorder (OCD). What Does Research Say About Cannabis and OCD? MORE
According to CTV News , the end of prohibition means cannabis is accessible to anyone who wants it – including scientists and researchers. Prohibition Created One-Sided Research. To be fair, there was some detailed, in-depth research into marijuana during prohibition. The problem is, this research focused on a single conclusion. Kerr recalls that initial research was “very pathologizing and unbalanced”. Research Now Much Easier to Conduct. MORE
There have recently been a series of developments advancing the Australian medicinal cannabis industry. Key Developments. Since legislation came into effect on 30 October 2016 to allow the legal cultivation, production and manufacturing of medical cannabis products in Australia, there have been a series of developments advancing the Australian medicinal cannabis industry. MORE
She is currently a law school professor teaching Marijuana and the Law at California Western School of Law and researcher under a contract with NHTSA and NORC on the topic of the prosecution of drugged driving cases. There are newly developing alternative testing devises that use oral fluid and drug breathalyzers. Several factors are contributing to the development and use of these alternatives. If you wish to re-publish this story please do so with following accreditation. MORE
Micron" or the "Company") (CSE: MWM, OTC: MICWF, Frankfurt: 7FM2), a leading developer of waste treatment systems for cannabis and food waste, today announced it has received a Health Canada Cannabis Research License to develop its aerobic waste digester technology for the treatment of cannabis waste. The post Micron Waste Receives Health Canada Cannabis Research License appeared first on Cannabis News | Lifestyle Tips | Expert Opinions | Stocks. VANCOUVER, Aug. MORE
Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. The government does allow cultivation of cannabis in special facilities for research purposes, but experts involved complain that it is inadequate. Lead researcher Sue Sinsley of SRI says: “While most states in the U.S. MORE
Extensive research in the United States and England on cannabis in the 1930s came to a halt with the beginning of World War II and did not pick up again afterwards due to the various laws and regulations that classified the plant as a drug.Legal issuescontinued to inhibit serious study until half a century ago, when Prof. Back then, accessing cannabis for research purposes was not necessarily simple. Now in his 80s and still very much active I his field of research, Prof. MORE
The post Canada: Research and Development Coordinator aphria inc.Leamington, ON first appeared on Cannabis Law Report. Are you looking for an exciting career in a thriving new industry that prides itself on innovation, professionalism, and collaboration? Here are Aphria inc. MORE
There were times when I was told you couldn’t even use ‘cannabis’ and ‘research’ in the same sentence,” he recalled. which is conducting millions of dollars worth of research on the use of cannabis to treat conditions including anxiety, insomnia and pain. Legalization has sparked a boom in pot research, generating funding, jobs and the need for laboratory space. The federal government is investing in marijuana research too. MORE
Panel Discussion “Research & Development for Medical Cannabis Purposes” – Panelists – Dr. Sandra Carrillo (Moderator) – (Medical Doctor, Professor, Co-Founder of Medicann … Read More. MORE
The Science Behind A Bad Habit To understand why we develop bad habits, it’s important to first get a grasp on the concept of reward-based learning. Education Featured Health Science brain development health mental health research study science science of cannabis smoking time MORE
Today the Centre for Medicinal Cannabis (CMC) in partnership with the Jamaican Medical Cannabis Corporation (JMCC) announce their Global Medical Cannabis Research Symposium. LONDON – July 31, 2019 / Canna Newswire / – Today the Centre for Medicinal Cannabis (CMC) in partnership with the Jamaican Medical Cannabis Corporation (JMCC) announce their Global Medical Cannabis Research Symposium which will take place in London on 18-19 September 2019. MORE
February 19, 2019 /Canna Newswire/ – Leading Edge Pharms, Inc. , (LEP) a biotechnology company developing novel cannabinoid therapies and innovative delivery systems, announced the results of a Tioga Research -led study, indicating that its proprietary cannabidiol-based (CBD) pain relief and anti-inflammatory agent, Silvidiol , effectively permeates the epidermis to reach somatic and neuropathic sensory receptors below the surface of the skin. MORE
As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Major research hospitals such as Montefiore in New York now use cannabis for treating cancer and HIV, as well as make new studies. Spain researches advanced use of cannabis medications. Research and Administration of Cannabis Medications. MORE
Research and Development Related Topics Cannabis Law Report
OCTOBER 18, 2020
The post Canada: Research and Development Coordinator aphria inc.Leamington, ON first appeared on Cannabis Law Report. Are you looking for an exciting career in a thriving new industry that prides itself on innovation, professionalism, and collaboration? Here are Aphria inc.
Cannabis Law Report
NOVEMBER 18, 2020
Panel Discussion “Research & Development for Medical Cannabis Purposes” – Panelists – Dr. Sandra Carrillo (Moderator) – (Medical Doctor, Professor, Co-Founder of Medicann … Read More.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
NOVEMBER 3, 2020
The polyps form inside the common and develop into colon cancers over time. Researchers looked at the activation of the cannabinoid receptor type 2 as a way of preventing colitis-associated colon cancer by myeloid cell deactivation of what is called the “upstream of IL-22 production”.
Leafly
DECEMBER 6, 2019
It's getting easier for CBD researchers to conduct studies of cannabidiol. Here are some developing trends in CBD research that bear watching. The post CBD research trends in 2019 appeared first on Leafly. CBD Science & tech cbd research science
Cannabis Chronicles
MAY 22, 2019
SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. We’ll hand them an iPad, and ask them to fill out a couple quick surveys,” said Michael McDonell, chair of WSU’s Collaboration on Cannabis Policy, Research and Outreach. McDonell said research institutions are limited in their access to cannabis users by federal laws that could affect funding.
Veriheal
NOVEMBER 13, 2020
Until recently, there has been little to no research available that examines the effects of cannabis in patients diagnosed with Obsessive-Compulsive Disorder (OCD). What Does Research Say About Cannabis and OCD?
|
Cannabis Law Report
SEPTEMBER 7, 2020
The post Is the Multidisciplinary Association for Psychedelic Studies (MAPS) too wedded to existing structures to truly make changes in development of psychedelics research first appeared on Cannabis Law Report.
Veriheal
JUNE 22, 2020
Whether or not cannabis use during pregnancy causes physical, cognitive, or mental impairments later in life has been something scientists and researchers have been investigating for decades. Unfortunately, much of the research conducted thus far have not shown the whole picture or clinical implications for children in real life. How Researchers Performed The Review. The research was conducted by Ciara A. News Research
Cannabis Life Network
MAY 25, 2019
NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabis worldwide, and UFC®, the world’s premier mixed martial arts organization, are excited to announce an exclusive, multi-year, multi-million dollar, global partnership that is expected to significantly advance further clinical research on the relationship between 100% hemp […]. EDMONTON, May 21, 2019 /CNW/ – Aurora Cannabis Inc.
Veriheal
JULY 16, 2020
The commission tasked with developing recommendations to improve mental health treatment for veterans concluded: Congress and the executive branch need to promote research into the therapeutic potential of cannabis and psychedelics such as psilocybin mushrooms and MDMA. Throughout its research and deliberation processes, the commission put the needs of veterans at the heart of its work. Research is Limited Due to Many Obstacles.
Cannabis Life Network
SEPTEMBER 8, 2020
The Science Behind A Bad Habit To understand why we develop bad habits, it’s important to first get a grasp on the concept of reward-based learning. Education Featured Health Science brain development health mental health research study science science of cannabis smoking time
|
Cannabis Law Report
MARCH 25, 2020
OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”). Valencia has stewarded Sapphire in the development of its unique patent-pending pipeline. “Sapphire Biotech’s research team is making impressive progress in the field of oncology, which is one of the main reasons we were attracted to the company,” said John W.
Veriheal
SEPTEMBER 18, 2020
Research Team to Study the Impact of CBD on Spinal Injury Pain. Professor Luke Henderson is set to be the study’s lead investigator and he explains that the unfortunate truth for more than half of spinal cord injury patients is the development of chronic pain.
MGC Pharma
FEBRUARY 20, 2018
The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon. Researched and developed by Slovenia’s leading dermatologist, Dr Rok Devjak, MD PhD, over an 80 day period, Dr Devjak tested three of MGC Pharma’s upcoming products.
Medicinal Marijuana Association
AUGUST 27, 2019
Extensive research in the United States and England on cannabis in the 1930s came to a halt with the beginning of World War II and did not pick up again afterwards due to the various laws and regulations that classified the plant as a drug.Legal issuescontinued to inhibit serious study until half a century ago, when Prof. Back then, accessing cannabis for research purposes was not necessarily simple. Now in his 80s and still very much active I his field of research, Prof.
Cannabis Law Report
OCTOBER 12, 2019
There have recently been a series of developments advancing the Australian medicinal cannabis industry. Key Developments. Since legislation came into effect on 30 October 2016 to allow the legal cultivation, production and manufacturing of medical cannabis products in Australia, there have been a series of developments advancing the Australian medicinal cannabis industry.
Cannabis Law Report
NOVEMBER 22, 2019
She is currently a law school professor teaching Marijuana and the Law at California Western School of Law and researcher under a contract with NHTSA and NORC on the topic of the prosecution of drugged driving cases. There are newly developing alternative testing devises that use oral fluid and drug breathalyzers. Several factors are contributing to the development and use of these alternatives. If you wish to re-publish this story please do so with following accreditation.
Puff Puff Post
JANUARY 24, 2019
There were times when I was told you couldn’t even use ‘cannabis’ and ‘research’ in the same sentence,” he recalled. which is conducting millions of dollars worth of research on the use of cannabis to treat conditions including anxiety, insomnia and pain. Legalization has sparked a boom in pot research, generating funding, jobs and the need for laboratory space. The federal government is investing in marijuana research too.
Canna Law Blog
MAY 7, 2020
At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts. What you may not know is that the federal government actually has its own stash of cannabis for limited patient distribution and limited research purposes that it houses at the University of Mississippi (a/k/a) Ole Miss in Oxford, Mississippi.
Canna Newswire
AUGUST 20, 2019
SYDNEY, Australia – August 20, 2019 – The Office of Drug Control (ODC has announced the approval of Oz Medicann Pty Ltd licence for both Medicinal Cannabis and Cannabis Research. With these licences, Oz Medicann forges ahead with its evidence-based research across the whole cycle from seed to patient. This exciting development will allow the group to continue pioneering as an Australian medicinal cannabis healthcare company. MEDICAL CANNABIS RESEARCH
WeedAdvisor
JANUARY 15, 2019
According to CTV News , the end of prohibition means cannabis is accessible to anyone who wants it – including scientists and researchers. Prohibition Created One-Sided Research. To be fair, there was some detailed, in-depth research into marijuana during prohibition. The problem is, this research focused on a single conclusion. Kerr recalls that initial research was “very pathologizing and unbalanced”. Research Now Much Easier to Conduct.
Canna Law Blog
JULY 24, 2020
On Tuesday, July 21, the Food and Drug Administration (“FDA”) released draft guidance for clinical research related to the development and manufacturing of cannabis-based drugs, which gained particular interest following the legalization of hemp in December 2018.
Puff Puff Post
JANUARY 13, 2020
Now that retailers broadly sell CBD oil, it offers a number of challenges and opportunities to medical researchers. Preliminary Research on CBD Oil. Pharmacies, as more profitable companies, have the resources to research the other cannabinoids present in CBD oil. Pharmacies partner with companies that have an interest in cannabis research. Hospitals and universities have always been at the forefront of research on cannabis products.
Puff Puff Post
JANUARY 1, 2020
As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Major research hospitals such as Montefiore in New York now use cannabis for treating cancer and HIV, as well as make new studies. Spain researches advanced use of cannabis medications. Research and Administration of Cannabis Medications.
Cannabis Law Report
JUNE 28, 2020
In September of last year, Johns Hopkins University announced the launch of the nation’s first-ever psychedelic research center , a $17-million project to study the … Read More. Psy Business & Law News Partnered With CFN
NORML
SEPTEMBER 20, 2019
We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. Back then, Dr. Sisley just entered the national spotlight, known as the research doctor who’d been unfairly fired from the University of Arizona for simply trying to study medical marijuana. The court gave the DEA 30 days to respond to Dr. Sisley, SRI, and the other researchers who filed suit.
Cannabis Law Report
NOVEMBER 22, 2019
MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. MMJ will be utilizing its new products for an FDA approved treatment of multiple sclerosis (MS) and Huntington’s disease (HD).
WeedAdvisor
JULY 4, 2019
Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. The government does allow cultivation of cannabis in special facilities for research purposes, but experts involved complain that it is inadequate. Lead researcher Sue Sinsley of SRI says: “While most states in the U.S.
Freedom Leaf
OCTOBER 10, 2019
Raphael Mechoulam , an Israel bio-chemist and trailblazing cannabis researcher, announced last month a process to produce synthetic cannabinoid acids – chemical compounds that may be more stable than their plant-based counterparts. “This is exciting and unprecedented research,” said Dr. Mechoulam said in a press release. ” Dr. Mechaloum has been on the forefront of cannabis research for sixty years. Israel Leading the Way in Canna-Research and Policy.
Cannabis Law Report
DECEMBER 27, 2019
It is no surprise hence, given the relationship between cannabis users and heavy mobile app and internet use, that the cannabis industry is leveraging the next wave of technologies to fill knowledge gaps and accelerate awareness of research insights about consumers in adult-use cannabis and medical cannabis markets, in what is being referred to as Cannabis 3.0. Clinical trials are medical research projects involving human participants. Authored By : Arundati Dandapani.
Cannabis Life Network
AUGUST 27, 2019
Micron" or the "Company") (CSE: MWM, OTC: MICWF, Frankfurt: 7FM2), a leading developer of waste treatment systems for cannabis and food waste, today announced it has received a Health Canada Cannabis Research License to develop its aerobic waste digester technology for the treatment of cannabis waste. The post Micron Waste Receives Health Canada Cannabis Research License appeared first on Cannabis News | Lifestyle Tips | Expert Opinions | Stocks. VANCOUVER, Aug.
Cannabis Life Network
AUGUST 28, 2019
Yang Qu says: Cannabis is rapidly being transformed from an underground species into an industrial crop that awaits medical and agricultural development. The post UNB researcher receives grant to explore medical potential of cannabis appeared first on Cannabis News | Lifestyle Tips | Expert Opinions | Stocks.
Canna Newswire
JULY 31, 2019
Today the Centre for Medicinal Cannabis (CMC) in partnership with the Jamaican Medical Cannabis Corporation (JMCC) announce their Global Medical Cannabis Research Symposium. LONDON – July 31, 2019 / Canna Newswire / – Today the Centre for Medicinal Cannabis (CMC) in partnership with the Jamaican Medical Cannabis Corporation (JMCC) announce their Global Medical Cannabis Research Symposium which will take place in London on 18-19 September 2019.
Greencamp
AUGUST 16, 2018
In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. In the developing world, the rates of amyotrophic lateral sclerosis are under-investigated, but in Europe and North America ALS afflicts 2 per 100,000 people each year. Exploring the available research on ALS and cannabinoids.
Canna Newswire
FEBRUARY 19, 2019
February 19, 2019 /Canna Newswire/ – Leading Edge Pharms, Inc. , (LEP) a biotechnology company developing novel cannabinoid therapies and innovative delivery systems, announced the results of a Tioga Research -led study, indicating that its proprietary cannabidiol-based (CBD) pain relief and anti-inflammatory agent, Silvidiol , effectively permeates the epidermis to reach somatic and neuropathic sensory receptors below the surface of the skin.
Cannabis Law Report
NOVEMBER 10, 2019
The Partnership Seeks to Develop Cannabis-Based Products for the Treatment of Human Diseases, Beginning with Colon Cancer. CIB has a national reputation as a center of excellence for biological research,” said Brian Baca, CEO of Ikänik Farms. “We We look forward to working with some of Colombia’s leading academics, including clinical and technological specialists, to advance the development of cannabis-based medical treatments.”.
Cannabis Law Report
AUGUST 26, 2019
ASX-listed MGC Pharmaceuticals has partnered with the Slovenian Institute of Hop Research and Brewing, or “IHPS”, to carry out a ground-breaking, large-scale research project on the use of cannabis for medical purposes. IHPS is a public research, developmental, advisory and educational organisation principally focussed on research and advice in growing plants.
172 
Let's personalize your content